World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
153
Citations
79249
World Ranking
1052
National Ranking
604

Research.com Recognitions

  • 2005 - Member of the National Academy of Medicine (NAM)

Overview

Steven M. Larson is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their work spans a broad range of topics within the field of medicine, with a focus on radiology, nuclear medicine, and imaging. Most of their research is concentrated in the subfields of radiology, nuclear medicine, pulmonary and respiratory medicine, molecular biology, oncology, and genetics.

The main topics covered in their work include:

  • Radiopharmaceutical Chemistry and Applications
  • Medical Imaging Techniques and Applications
  • Prostate Cancer Treatment and Research
  • Monoclonal and Polyclonal Antibodies Research
  • Intraperitoneal and Appendiceal Malignancies
  • Neuroblastoma Research and Treatments
  • Thyroid Cancer Diagnosis and Treatment

Steven M. Larson has frequently collaborated with several coauthors, including:

  • Darren R. Veach
  • Nai-Kong V. Cheung
  • Sarah M. Cheal
  • Pat Zanzonico
  • Hong-Fen Guo

Their most common publication venues include:

  • Journal of Nuclear Medicine
  • Journal of Clinical Oncology
  • bioRxiv (Cold Spring Harbor Laboratory)
  • European Journal of Nuclear Medicine and Molecular Imaging
  • Theranostics

Recent papers authored or coauthored by Steven M. Larson illustrate their research interests and recent contributions:

  • "Pretargeting: A Path Forward for Radioimmunotherapy," 2022, Journal of Nuclear Medicine
  • "Phase 1 study of intraventricular 131I-omburtamab targeting B7H3 (CD276)-expressing CNS malignancies," 2022, Journal of Hematology & Oncology
  • "Dickkopf-1 Can Lead to Immune Evasion in Metastatic Castration-Resistant Prostate Cancer," 2020, JCO Precision Oncology
  • "2025 American Thyroid Association Management Guidelines for Adult Patients with Differentiated Thyroid Cancer," 2025, Thyroid
  • "A simple strategy to reduce the salivary gland and kidney uptake of PSMA-targeting small molecule radiopharmaceuticals," 2021, European Journal of Nuclear Medicine and Molecular Imaging

Steven M. Larson has been recognized as a member of the National Academy of Medicine since 2005.

Best Publications

  • The pharmacology of monoclonal antibodies.

    John N Weinstein;R. R. Eger;D. G. Covell;C. D.V. Black

  • Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality.

    C.Clifton Ling;John Humm;Steven Larson;Howard Amols

  • Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study.

    Howard I Scher;Tomasz M Beer;Celestia S Higano;Aseem Anand

  • Eradication of systemic B-cell tumors by genetically targeted human T lymphocytes co-stimulated by CD80 and interleukin-15.

    Renier J. Brentjens;Jean Baptiste Latouche;Elmer Santos;Francesc Marti

  • Selumetinib-Enhanced Radioiodine Uptake in Advanced Thyroid Cancer

    Alan L. Ho;Ravinder K. Grewal;Rebecca Leboeuf;Eric J. Sherman

  • Progress and Promise of FDG-PET Imaging for Cancer Patient Management and Oncologic Drug Development

    Gary J. Kelloff;John M. Hoffman;Bruce Johnson;Howard I. Scher

  • Consensus Recommendations for the Use of 18F-FDG PET as an Indicator of Therapeutic Response in Patients in National Cancer Institute Trials

    Lalitha K. Shankar;John M. Hoffman;Steve Bacharach;Michael M. Graham

  • Circulating Tumor Cell Number and Prognosis in Progressive Castration-Resistant Prostate Cancer

    Daniel C. Danila;Glenn Heller;Gretchen A. Gignac;Rita Gonzalez-Espinoza

  • Tumor Treatment Response Based on Visual and Quantitative Changes in Global Tumor Glycolysis Using PET-FDG Imaging. The Visual Response Score and the Change in Total Lesion Glycolysis.

    Steven M. Larson;Yusuf Erdi;Timothy Akhurst;Madhu Mazumdar

  • Clinical translation of an ultrasmall inorganic optical-PET imaging nanoparticle probe

    Evan Phillips;Oula Penate-Medina;Pat B. Zanzonico;Richard D. Carvajal

  • Multimodal silica nanoparticles are effective cancer-targeted probes in a model of human melanoma

    Miriam Benezra;Oula Penate-Medina;Pat B. Zanzonico;David Schaer

  • Positron emission tomography in Alzheimer's disease

    Ranjan Duara;Cheryl L. Grady;James V. Haxby;M. Sundaram

  • Genetically Targeted T Cells Eradicate Systemic Acute Lymphoblastic Leukemia Xenografts

    Renier J. Brentjens;Elmer Santos;Yan Nikhamin;Raymond Yeh

  • Real-Time Prognosis for Metastatic Thyroid Carcinoma Based on 2-[18F]Fluoro-2-Deoxy-d-Glucose-Positron Emission Tomography Scanning

    Richard J. Robbins;Qiang Wan;Ravinder K. Grewal;Roland Reibke

  • Segmentation of lung lesion volume by adaptive positron emission tomography image thresholding.

    Yusuf E. Erdi;O. Mawlawi;Steven M. Larson;M. Imbriaco

  • Targeted α particle immunotherapy for myeloid leukemia

    Joseph G. Jurcic;Steven M. Larson;Steven M. Larson;George Sgouros;George Sgouros;Michael R. McDevitt;Michael R. McDevitt

  • A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer.

    Andrew M Scott;Greg Wiseman;Sydney Welt;Alex Adjei

  • Radioimmunotherapy with alpha-emitting nuclides

    Michael R. McDevitt;George Sgouros;Ronald D. Finn;John L. Humm

  • Phase II Multicenter Study of Abiraterone Acetate Plus Prednisone Therapy in Patients With Docetaxel-Treated Castration-Resistant Prostate Cancer

    Daniel C. Danila;Michael J. Morris;Johann S. De Bono;Charles J. Ryan

  • Prediction of survival in glioma patients by means of positron emission tomography

    N.J. Patronas;G. Di Chiro;C. Kufta;D. Bairamian

Frequent Co-Authors

John L. Humm
John L. Humm Memorial Sloan Kettering Cancer Center
Jorge A. Carrasquillo
Jorge A. Carrasquillo Memorial Sloan Kettering Cancer Center
Michael J. Morris
Michael J. Morris Memorial Sloan Kettering Cancer Center
Howard I. Scher
Howard I. Scher Memorial Sloan Kettering Cancer Center
Heiko Schöder
Heiko Schöder Memorial Sloan Kettering Cancer Center
Nai-Kong V. Cheung
Nai-Kong V. Cheung Memorial Sloan Kettering Cancer Center
Mithat Gonen
Mithat Gonen Memorial Sloan Kettering Cancer Center
Jason S. Lewis
Jason S. Lewis Memorial Sloan Kettering Cancer Center
Homer A. Macapinlac
Homer A. Macapinlac The University of Texas MD Anderson Cancer Center
Andrew M. Scott
Andrew M. Scott La Trobe University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a highly competitive field, but there are related online degrees and fulfilling career pathways available for students seeking flexible options. For those without a nursing background, direct entry msn programs for non-nursing majors online offer an accelerated route into advanced nursing by allowing you to earn a master’s degree directly, even if your bachelor’s isn’t in nursing.

If you are concerned about admission difficulty, exploring what is the easiest nursing program to get into may help you identify institutions with higher acceptance rates or more flexible prerequisites.

Not all healthcare careers require a clinical background. For example, medical billing and coding is a strong alternative with many certified programs available online. Look for online medical billing and coding schools that accept fafsa if you need financial support.

Furthermore, some nursing schools have moved away from traditional entrance exams. If testing is a concern, consider a nursing school without teas test requirements, making the application process a bit simpler.

Best Scientists Citing Steven M. Larson

Trending Scientists

Recently Published Articles